Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | DNA gyrase (type II topoisomerase), subunit A | References | |
Escherichia coli | DNA gyrase, subunit B | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 0.0473 | 1 | 1 | |
Trypanosoma brucei | DNA topoisomerase ii | 0.0121 | 0.1636 | 0.1532 |
Mycobacterium tuberculosis | DNA gyrase (subunit A) GyrA (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0318 | 0.6313 | 1 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0069 | 0.0383 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0473 | 1 | 1 |
Toxoplasma gondii | DNA gyrase/topoisomerase IV, A subunit domain-containing protein | 0.0318 | 0.6313 | 0.6166 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0121 | 0.1636 | 0.1532 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0121 | 0.1636 | 0.1532 |
Chlamydia trachomatis | DNA gyrase subunit A | 0.0318 | 0.6313 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0176 | 0.2932 | 0.2844 |
Plasmodium vivax | DNA gyrase subunit A, putative | 0.0318 | 0.6313 | 1 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0153 | 0.2386 | 0.2419 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0088 | 0.085 | 0.0486 |
Toxoplasma gondii | sedoheptulose-1,7-bisphosphatase | 0.0176 | 0.2932 | 0.265 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0473 | 1 | 1 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0069 | 0.0383 | 0.5 |
Toxoplasma gondii | fructose-bisphospatase I | 0.0176 | 0.2932 | 0.265 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0473 | 1 | 1 |
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0069 | 0.0383 | 0.5 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0069 | 0.0383 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase subunit A | 0.0318 | 0.6313 | 1 |
Plasmodium falciparum | DNA gyrase subunit A | 0.0318 | 0.6313 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0473 | 1 | 1 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0121 | 0.1636 | 0.1532 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0473 | 1 | 1 |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.0176 | 0.2932 | 0.2844 |
Onchocerca volvulus | Putative DNA topoisomerase 2, mitochondrial | 0.0069 | 0.0383 | 0.5 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0473 | 1 | 1 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0473 | 1 | 1 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0153 | 0.2386 | 0.3378 |
Mycobacterium ulcerans | DNA gyrase subunit A | 0.0318 | 0.6313 | 1 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0473 | 1 | 1 |
Treponema pallidum | DNA gyrase, subunit A (gyrA) | 0.0318 | 0.6313 | 1 |
Mycobacterium leprae | Probable DNA gyrase (subunit A) GyrA (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) | 0.0152 | 0.2354 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0176 | 0.2932 | 0.2844 |
Giardia lamblia | DNA topoisomerase II | 0.0064 | 0.0269 | 0.5 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0153 | 0.2386 | 0.3378 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 14 uM | Inhibition of Escherichia coli GyrB A2B2 subunits assessed reduction in DNA supercoiling activity by malachite green dye based by spectrophotometry | ChEMBL. | 25137573 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.